InJanuary 2022, the Company completed the submission of a supplemental Biologics Licensing Application (sBLA) to FDA seeking approval for a M/W/F IM dosing schedule for Rylaze. InApril 2022, the Company completed the submission of an sBLA to FDA seeking approval for IV administration...
In May 2022, the Company completed the Marketing Authorization Application submission to European Medicines Agency for a MWF dosing schedule and IM and intravenous (IV) administration for JZP458 (approved as Rylaze in the U.S.) with potential for approval in 2023. The Company ...
Production schedule delays-Even though an automotive parts manufacturer had the systems in place to receive EDI (Electronic Data Interchange) orders, there was no integration to push the orders into t... please help me. Berlin and Co made payments totaling $64,000 for rent during the year end...
OnAugust 27th, the Tour de Cure, presented byWheaton Precious Metals, raised CA$6.3 million for theBC Cancer Foundation. The event is B.C.'s largest cycling fundraiser attracting over 1,100 participants. Since 2014, Wheaton has donated over CA$3.2 million towards crucial ad...
CONFIDENTIAL Page 25 June 2022 Veklury® Clinical Study Results Remdesivir (RDV; GS-5734™) Study GS-US-540-5774 Interim 2 (Final Part A) Clinical Study Report STUDY SYNOPSIS Study GS-US-540-5774 Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 USA Final Title of Study...
“2022 was a challenging year for the company. We faced downstream impacts from the December 2021 fire at our Rocky Mount fulfillment center throughout the year, while also experiencing macro pressure that impacted consumer demand,” said David Rawlinson, President and CEO...
(Refer to the Non-GAAP Financial Information schedule attached to this release for additional details.) Items included in the Company’s net income for 2022 are listed below, and fourth quarter activity, if any, is highlighted for each item: a $6.1 million net credit related to fai...
Plan Schedules with Laser Precision Friendly, Easy User Interface & Views Optimize Machinery, Shifts & Operations Real-Time Scheduling & Schedule Views Leverage Automated Intelligence Electronically Connect with SuppliersLet’s Schedule a Demo!215.639.9540 | sales@amtechsoftware.com | www.amtechsoftware....